English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/48097
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Human SREBP1c expression in liver is directly regulated by Peroxisome Proliferator-activated Receptor α (PPARα)

AuthorsFernández-Alvarez, Ana Julia CSIC ORCID; Alvarez, María Soledad; Gonzalez, Raúl; Cucarella, Carme CSIC ; Muntané, Jordi; Casado, Marta CSIC ORCID
Issue Date2-May-2011
PublisherAmerican Society for Biochemistry and Molecular Biology
CitationJournal of Biological Chemistry 286(24): 21466-77 (2011 Jun 17)
AbstractSterol regulatory element binding proteins (SREBPs) regulate the expression of a number of enzymes, which catalyze the synthesis of fatty acids, cholesterol, triglycerides, and phospholipids. SREBP1c is the most relevant isoform in the adult liver, and its expression is controlled by the nutritional state. Transcriptional regulation studies into the SREBP1c gene, performed in the last few years, have improved our knowledge of the variability of signals that converge on its promoter region. Insulin, cholesterol derivatives, T3 and other endogenous molecules have been demonstrated to regulate the SREBP1c expression, particularly in rodents. The present study aimed to perform a detailed analysis of the human SREBP1c gene promoter structure in liver cells by focusing on responses to diverse metabolic signals. Serial deletion and mutation assays reveal that both SREBP (SRE) and LXR (LXRE) response elements are involved in SREBP1c transcription regulation mediated by insulin and cholesterol derivatives. We discovered that peroxisome proliferation-activated receptor alpha (PPARα) agonists enhance the activity of the SREBP1c promoter; a DR1 element, at -453 in the human promoter was involved in this activation. Moreover, PPARα agonists act in cooperation with LXR or insulin to induce lipogenesis. Collectively, our results identify PPARα as a novel regulatory factor in SREBP1c regulation which plays a relevant role in the interplay between lipids and insulin metabolic regulation.
Description12 páginas, 8 figuras. PMID:21540177[PubMed] PMCID:PMC3122206[Available on 2012/6/17]
Publisher version (URL)http://dx.doi.org/10.1074/jbc.M110.209973
URIhttp://hdl.handle.net/10261/48097
DOIhttp://dx.doi.org/10.1074/jbc.M110.209973
ISSN0021-9258
E-ISSN1083-351X
Appears in Collections:(IBV) Artículos
Files in This Item:
File Description SizeFormat 
Fernandez-Alvarez 2011 JBC.pdf387,1 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.